Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Surg ; 222(5): 944-951, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34024629

ABSTRACT

BACKGROUND: Near infrared autofluorescence (NIRAF) detection has previously demonstrated significant potential for real-time parathyroid gland identification. However, the performance of a NIRAF detection device - PTeye® - remains to be evaluated relative to a surgeon's own ability to identify parathyroid glands. METHODS: Patients eligible for thyroidectomy and/or parathyroidectomy were enrolled under 6 endocrine surgeons at 3 high-volume institutions. Participating surgeons were categorized based on years of experience. All surgeons were blinded to output of PTeye® when identifying tissues. The surgeon's performance for parathyroid discrimination was then compared with PTeye®. Histology served as gold standard for excised specimens, while expert surgeon's opinion was used to validate in-situ tissues. RESULTS: PTeye® achieved 92.7% accuracy across 167 patients recruited. Junior surgeons (<5 years of experience) were found to have lower confidence in parathyroid identification and higher tissue misclassification rate per specimen when compared to PTeye® and senior surgeons (>10 years of experience). CONCLUSIONS: NIRAF detection with PTeye® can be a valuable intraoperative adjunct technology to aid in parathyroid identification for surgeons.


Subject(s)
Intraoperative Period , Optical Imaging/methods , Parathyroid Glands/anatomy & histology , Adult , Aged , Aged, 80 and over , Clinical Competence , Female , Humans , Male , Middle Aged , Parathyroid Glands/diagnostic imaging , Parathyroid Glands/surgery , Spectroscopy, Near-Infrared , Young Adult
2.
Surg Clin North Am ; 99(4): 759-771, 2019 Aug.
Article in English | MEDLINE | ID: mdl-31255205

ABSTRACT

Adrenocortical cancer is a rare disease. Prognosis remains poor but is improving. In this article, initial presentation, biochemical and imaging evaluation, surgical approach to resection, and postoperative care are reviewed. Prognosis, patterns of recurrence, treatment of metastatic disease using medical therapy and other surgical and nonsurgical therapies are discussed.


Subject(s)
Adrenal Cortex Neoplasms/therapy , Adrenalectomy/methods , Adrenocortical Carcinoma/therapy , Antineoplastic Agents/therapeutic use , Chemotherapy, Adjuvant , Humans , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...